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Abstract: Introduction: Undoubtedly, HIV/AIDS is one of the most important emerging infectious disease in the late 
twentieth century; and its control is possible only with proper and organized program. To attain this goal, one of the most 
serious issues is the budget planning and distribution. The present study calculated the total costs of AIDS in Voluntary 
Counseling and Testing center of Imam Khomeini Hospital in 2010-2011. 
Methods: The total cost of AIDS at this center was divided into four categories: health care, training and educating, 
research and services. All costs for 2010-2011 were extracted and classified based on documents and bills which were 
found in the center. 
Results: According to the calculations, the center had a total of 6,603,479,058 IRR in 2010-2011, of which 49.5% 
(3,271,089,796 IRR) was allocated for health care expenditure, 20.3% (1,335,186,000 IRR) for research, 12.6% 
(834,000,000 IRR) for training and 17.6% (1,163,203,262 IRR) for services. The average expense for each person living 
with HIV was 2276 US dollars. The cost of treatment by drugs for each person eligible for treatment was 782 US dollars. 
Conclusion: The percentage of budget distribution in the center is equal to the same percentage in low and middle 
income countries; although, more percentage is allocated for research than the mentioned countries. Also, the 
expenditure spent for treatment by drugs is more than the average of the same found in low and middle income 
countries. Overall, the budget distribution in this center is almost in accordance with the international standards. 
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INTRODUCTION 
AIDS is characterized by the progressive 
destruction of a person’s immune system and is the 
late and most serious stage of HIV infection [1]. 
Globally, an estimated 35.3 (32.2–38.8) million people 
were living with HIV in 2012. An increase from previous 
years as more people are receiving the life-saving 
antiretroviral therapy. There were 2.3 (1.9–2.7) million 
new HIV infections globally, showing a 33% decline in 
the number of new infections from 3.4 (3.1–3.7) million 
in 2001. At the same time the number of AIDS deaths 
is also declining with 1.6 (1.4–1.9) million AIDS deaths 
in 2012, down from 2.3 (2.1–2.6) million in 2005 [2]. 
The medical cost and economic burden to society of 
the HIV/AIDS epidemic have attracted some but  
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substantially less attention. Early costing studies in the 
pre-ART (antiretroviral therapy) era examined the 
direct medical costs associated with the morbidity and 
mortality of AIDS focusing mainly on the costs of 
hospitalization [3]. The economic burden measured by 
direct medical costs has shifted from inpatient costs 
(i.e., hospitalization) to outpatient costs primarily 
reflected as the cost of the antiretroviral drugs, 
outpatient visits, and laboratory tests [3-5]. 
Furthermore, HIV prevalence is increasing in western 
countries as a consequence of falling death rates [1]. 
Information on the direct costs of treatment is 
important since it provides a basis for health planners 
to allocate budgets or reimburse specific categories of 
expenditures. It also enables policymakers, when faced 
with changes in prevalence, that currently occurring 
with the spread of HIV infection among injection drug 
users to make more informed choices between 
programmes. To optimally allocate scarce economic 
resources to prevention and treatment programmes, 
planners require accurate, up-to-date estimates of the 
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direct costs of treatment [1, 6]. Although economic 
evaluation is an important approach for establishing 
priorities for health interventions [1, 7, 8], in practice 
this type of evaluation has been of limited value in 
HIV/AIDS because of the paucity of accurate cost data 
[1, 9]. 
According to statistics collected from medical 
schools and health services In Islamic Republic of Iran, 
till October of 2013, the total contracting HIV/AIDS was 
reported 26125 that 89.8% were male and 10.2% were 
female [10].  
Whereas the death and disease of HIV/AIDS is 
common in countries with low/middle income, good 
investments are more important than ever. With 
estimation of HIV/AIDS cost, the programme managers 
and planners dealing with HIV/AIDS to make informed 
decisions about resource allocation and also in 
responding to the HIV/AIDS epidemic the costs and 
consequences of the initiatives proposed in an AIDS 
programme must be known to the decision-makers to 
make best use of scarce resources.  
The estimation cost of HIV/AIDS is studied in many 
countries and many articles described it, for example 
Dodds.C et.al studied the cost of HIV/AIDS in Canada 
in 1999. According to their study, total direct costs of 
HIV/AIDS was $600 million a year, the shift to 
expensive highly active antiretroviral therapy (HAART) 
treatments in 1996, that delay the onset of AIDS and 
prolong the lives of HIV patients, has increased direct 
patient costs. Average monthly health care costs per 
person for the four HIV/AIDS stages increased by 
120% for the CD4 count >500 cells/µL, by 85% for the 
499-200 cells/µL, by 51% for the 199-75 cells/µL, and 
by 21% for AIDS victims (CD4 count <75 cells/µL) 
following the introduction of HAART [11, 12]. The aim 
of this study was to calculate the cost of HIV/AIDS in 
the Voluntary Counseling and Testing (VCT) Center of 
Imam Khomeini Hospital between 2010-2011. 
MATERIALS AND METHODS 
All clients of AIDS counseling center receive 
counseling and visiting services of this center. But from 
clients of AIDS counseling center, there are cases that 
refer to this center just for fear of HIV infection or for 
gain information about AIDS and the ways of HIV 
transmission, these cases are guided by the counseling 
center without enrolling in the center. Only cases with 
risky behavior, are enrolled and taken the initial testing. 
After HIV infection is confirmed by testing, to accept the 
current situation, consultation is done by the center’s 
aware counselor. 
After this, if the infected person be married, with 
consent of the person, to accept in the family, disease 
process, the way of transmission, particularly of 
sexually, prevention ways of infection and how to use 
condom, consultation will be given to the spouse. If the 
person be single, just with consent of the person and in 
the necessity to emotionally and clinical support, family 
counseling will be done and the acceptance of an 
infected person in the family is emphasized. This is 
assured that despite living with an infected person, the 
HIV is not transmitted and also disease process, the 
way of transmission will explain and testing for the 
presence of HIV for family if they had a risky behavior 
is emphasized. Then, the practitioner examines the 
patient carefully and record diagnostic findings in the 
form of clinical assessment of HIV/AIDS. To confirm 
and finalize the diagnosis from people who have a 
positive ELISA test, ELISA test is done again and also 
a Western Blot test is done for these patients. By 
definition, we say that a person is HIV positive and 
suffering from AIDS when CD4 count is declined under 
200 cells per microliter or the person suffering from one 
of the cellular immunity disease, so medication for 
these patients begins. This study was cross-sectional 
and descriptive and was based on all patients that 
referred to the counseling center in 2010 and received 
one of the services that this center provides. The 
information gathered through study the documents, 
questionnaires and interviews with staff of center. To 
calculate the cost in the VCT Center of Imam Khomeini 
Hospital in 2010-2011, these costs were classified into 
four sections and the cost of every section was 
calculated and these costs were summed. 
These sections were: 
a. Health-therapeutic that contains test and 
imaging, drug and vaccine 
b. Training that contains publish of AIDS book and 
publish leaflet and posters, seminar, congress, 
nutrition workshops and educational workshops 
of positive club 
c. Research that contains first three months, 
second three months, third three months and 
fourth three months. 
d. Services that contains personnel of VCT, 
equipment of VCT, setting up new sexually 
transmitted infections (STIs) unit, telephone of 
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VCT, water, electricity and fuel consumption and 
positive club. 
Profile of clients to the center was confidential. For 
data analysis, SPSS (19) software was used. 
RESULTS 
In this study, 9271 people were referred to the 
counseling center. Number of patients that referred to 
the center and number of patients with positive HIV and 
AIDS and number of patients that catch treatment are 
displayed in Table 1. 
As it was mentioned, the total cost includes Health-
therapeutic, training, research and services cost. Table 
2 displays the cost of these sections separately. 
Table 2: The Cost of Health-Therapeutic, Training, 
Research and Services in the VCT Center of 
Imam Khomeini Hospital in 2010-2011 
 Cost (IRR) percent 
Health-therapeutic 
Test and imaging 539,772,296  
Drug 2,657,542,500  
Vaccination 73,775,000  
Total 3,271,089,796 49.5% 
Training 
Publish of AIDS book 50,000,000  
Publish leaflet and posters 15,000,000  
Seminar 103,000,000  
Congress 600,000,000  
Nutrition workshops 16,000,000  
Education workshops of positive 
club 
50,000,000  
Total 834,000,000 12.6% 
 
(Table 2). Continued. 
Research 
First three months 368,000,000  
Second three months 568,500,000  
Third three months 226,900,000  
Fourth three months 171,786,000  
Total 1,335,186,000 20.3% 
Services 
Personnel of VCT 792,000,000  
Equipment of VCT 12,000,000  
Setting up new STIs unit 66,000,000  
Telephone of VCT 7,127,700  
Water, electricity and fuel 
consumption 
2,775,562  
Positive club 283,300,000  
Total 1,163,203,262 17.6% 
 
And Table 3 displays the summary of the Table 2. 
Table 3: Summary of Total Costs 
 Cost (IRR) percent 
Health-therapeutic 3,271,089,796 49.5% 
Training 834,000,000 12.6% 
Research 1,335,186,000 20.3% 
Services 1,163,203,262 17.6% 
Total costs 6,603,479,058 100% 
DISCUSSION 
According to the results of this study, the distribution 
of money spent on HIV/AIDS in the Imam Khomeini 
VCT center in 2010-2011 is relatively similar to low and 
middle income countries. In both cases most of the 
cost is for health therapeutic, while the cost for 
research in low and middle income countries was 
Table 1: Number of Patients that Referred to the Center and Number of Patients with Positive HIV and AIDS and 
Number of Patients that Received Treatment 
Gender 
 First quarter Second quarter Third quarter Fourth quarter Total male female 
Referred 2007 2294 2583 2387 9271   
New counseling 292 304 324 272 1192   
Number of HIV+ 65 71 66 37 239 75% 25% 
Number of AIDS patients 43 34 35 37 149 73% 27% 
Total new cases treated 79 92 87 72 330 64% 36% 
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relatively low (8% in 2008) but this cost is more in the 
Imam Khomeini VCT center (20.3% in 2010-2011). 
This issue shows that the research in this center is 
important. The VCT center of Imam Khomeini Hospital 
has spent on average 2276$ for each person with HIV/ 
AIDS in 2010-2011, compared to the corresponding 
figure in low and middle income countries, more 
funding for each person is allocated. According to the 
results, in comparison with other countries, the price of 
drugs in Iran is high. The cost of training was 12.6% of 
total cost and this offered that more cost must be 
allocated for training. Also, this center is one of the 
most important center in Iran in the field of HIV/AIDS 
control, the cost that is allocated for patients and drugs’ 
research and training and services are more than the 
country’s average, so similar centers in various 
province must be consider and the existence of a 
proper reference for the number of patients and 
mortality of AIDS to future studies is important. 
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